Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice

Cerebral cavernous malformations (CCMs) are common brain vascular dysplasias that are prone to acute and chronic hemorrhage with significant clinical sequelae. The pathogenesis of recurrent bleeding in CCM is incompletely understood. Here, we show that central nervous system hemorrhage in CCMs is as...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood Jg. 133; H. 3; S. 193
Hauptverfasser: Lopez-Ramirez, Miguel Alejandro, Pham, Angela, Girard, Romuald, Wyseure, Tine, Hale, Preston, Yamashita, Atsuki, Koskimäki, Janne, Polster, Sean, Saadat, Laleh, Romero, Ignacio A, Esmon, Charles T, Lagarrigue, Frederic, Awad, Issam A, Mosnier, Laurent O, Ginsberg, Mark H
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 17.01.2019
Schlagworte:
Adult
Animals
Anticoagulants - metabolism
Apoptosis Regulatory Proteins - physiology
Blood Coagulation
Case-Control Studies
Cerebral Hemorrhage - blood
Cerebral Hemorrhage - diagnosis
Cerebral Hemorrhage - etiology
Endothelial Protein C Receptor - metabolism
Endothelium, Vascular - metabolism
Endothelium, Vascular - pathology
Hemangioma, Cavernous, Central Nervous System - complications
Hemangioma, Cavernous, Central Nervous System - metabolism
Hemangioma, Cavernous, Central Nervous System - physiopathology
Humans
KRIT1 Protein - physiology
Membrane Proteins - physiology
Mice
Mice, Knockout
Protein C - metabolism
Proto-Oncogene Proteins - physiology
Signal Transduction
Thrombomodulin - blood
Young Adult
ISSN:1528-0020, 1528-0020
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cerebral cavernous malformations (CCMs) are common brain vascular dysplasias that are prone to acute and chronic hemorrhage with significant clinical sequelae. The pathogenesis of recurrent bleeding in CCM is incompletely understood. Here, we show that central nervous system hemorrhage in CCMs is associated with locally elevated expression of the anticoagulant endothelial receptors thrombomodulin (TM) and endothelial protein C receptor (EPCR). TM levels are increased in human CCM lesions, as well as in the plasma of patients with CCMs. In mice, endothelial-specific genetic inactivation of ( ) or ( ), which cause CCM formation, results in increased levels of vascular TM and EPCR, as well as in enhanced generation of activated protein C (APC) on endothelial cells. Increased TM expression is due to upregulation of transcription factors KLF2 and KLF4 consequent to the loss of or Increased TM expression contributes to CCM hemorrhage, because genetic inactivation of 1 or 2 copies of the gene decreases brain hemorrhage in mice. Moreover, administration of blocking antibodies against TM and EPCR significantly reduced CCM hemorrhage in mice. Thus, a local increase in the endothelial cofactors that generate anticoagulant APC can contribute to bleeding in CCMs, and plasma soluble TM may represent a biomarker for hemorrhagic risk in CCMs.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1528-0020
1528-0020
DOI:10.1182/blood-2018-06-856062